SPP Pharmaclon Ltd.
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis (NCT06118619) | SPP Pharmaclon Ltd. | 2022-06-01 |
| Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis (NCT05359315) | SPP Pharmaclon Ltd. | 2022-04-15 |
| Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19 (NCT05054114) | SPP Pharmaclon Ltd. | 2020-12-21 |
| Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19 (NCT05386446) | SPP Pharmaclon Ltd. | 2020-04-23 |
| Study of the Use of the Drug Ingaron in Patients With COVID-19 (NCT05386459) | SPP Pharmaclon Ltd. | 2020-04-21 |
Track SPP Pharmaclon Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.